3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
8
Polycystic Ovary Syndrome
3
Peripheral Nervous System Diseases
2
Obesity
2
Neoplasms
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Triple Negative Breast Neoplasms
1
Tracheal Diseases
1
TP53 Y220C Mutation
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Overweight
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Multiple Myeloma
1
Motor Activity
1
Mesothelioma
1
Meningioma
1
Medulloblastoma
1
Interventions
Exercise
55
Resistance Training
9
Nutritional Status
6
Control Groups
5
Surveys and Questionnaires
4
Standard of Care
4
Diet
4
Preoperative Exercise
3
Physical Therapy Modalities
3
Nutrition Assessment
3
Methods
3
High-Intensity Interval Training
3
Counseling
3
lime
2
Vitamin D
2
Palliative Care
2
Interviews as Topic
2
Exercise Therapy
2
Exercise Test
2
Dosage Forms
2
Diet Therapy
2
Blood Specimen Collection
2
pembrolizumab
1
diacetamate
1
cytisine
1
cemiplimab
1
beta-Glucans
1
avelumab
1
YES1 protein, human
1
Whey Proteins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Motor Activity
×
Tablets
×
1 year
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled